Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Carotid Plaque Composition by MRI During Lipid Lowering Therapy
NCT00715273Phase 4Completed
- Sponsor
- University of Washington
- Start
- May 2001
- Primary completion
- Dec 2018
- Modality
- Polymer-based Nanoparticles, Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of niacin, colesevelam in atherosclerosis, coronary artery disease (CAD), carotid artery disease, sponsored by University of Washington. Started May 2001; status: completed.
02
Drugs
niacincolesevelam
03
Conditions
atherosclerosiscoronary artery disease (CAD)carotid artery disease
Beyond the preview
Go deeper on NCT00715273.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00715273.